Regulated expression of positive and negative regulatory factors controls the extent and duration of T cell adaptive immune response preserving the organism's integrity. Calreticulin (CRT) is a major Ca2+ buffering chaperone in the lumen of the endoplasmic reticulum. Here we investigated the impact of CRT deficiency on T cell function in immunodeficient mice reconstituted with fetal liver crt−/− hemopoietic progenitors. These chimeric mice displayed severe immunopathological traits, which correlated with a lower threshold of T cell receptor (TCR) activation and exaggerated peripheral T cell response to antigen with enhanced secretion of inflammatory cytokines. In crt−/− T cells TCR stimulation induced pulsatile cytosolic elevations of Ca2+ concentration and protracted accumulation of nuclear factor of activated T cells in the nucleus as well as sustained activation of the mitogen-activated protein kinase pathways. These observations support the hypothesis that CRT-dependent shaping of Ca2+ signaling critically contributes to the modulation of the T cell adaptive immune response.
Skip Nav Destination
Article navigation
20 February 2006
Article|
February 21 2006
Regulation of peripheral T cell activation by calreticulin
Simona Porcellini,
Simona Porcellini
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Search for other works by this author on:
Elisabetta Traggiai,
Elisabetta Traggiai
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Search for other works by this author on:
Ursula Schenk,
Ursula Schenk
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Search for other works by this author on:
Denise Ferrera,
Denise Ferrera
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Search for other works by this author on:
Michela Matteoli,
Michela Matteoli
2Department of Medical Pharmacology, CNR Institute of Neuroscience, Cellular and Molecular Pharmacology, Center of Excellence for Neurodegenerative Diseases, 20129 Milano, Italy
Search for other works by this author on:
Antonio Lanzavecchia,
Antonio Lanzavecchia
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Search for other works by this author on:
Marek Michalak,
Marek Michalak
3Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
Search for other works by this author on:
Fabio Grassi
Fabio Grassi
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Search for other works by this author on:
Simona Porcellini
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Elisabetta Traggiai
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Ursula Schenk
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Denise Ferrera
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Michela Matteoli
2Department of Medical Pharmacology, CNR Institute of Neuroscience, Cellular and Molecular Pharmacology, Center of Excellence for Neurodegenerative Diseases, 20129 Milano, Italy
Antonio Lanzavecchia
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
Marek Michalak
3Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
Fabio Grassi
1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
CORRESPONDENCE Fabio Grassi: [email protected]
Abbreviations used: [Ca2+]i, intracellular free Ca2+; CRT, calreticulin; DKO, double knockout; DP, double positive; FLP, fetal liver hemopoietic progenitor; MAPK, mitogen-activated protein kinase; OVAp, OVA peptide; SERCA, sarco-endoplasmic reticulum calcium transport ATPase; SP, single positive; T reg, T regulatory.
Received:
July 28 2005
Accepted:
January 20 2006
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2006
J Exp Med (2006) 203 (2): 461–471.
Article history
Received:
July 28 2005
Accepted:
January 20 2006
Citation
Simona Porcellini, Elisabetta Traggiai, Ursula Schenk, Denise Ferrera, Michela Matteoli, Antonio Lanzavecchia, Marek Michalak, Fabio Grassi; Regulation of peripheral T cell activation by calreticulin . J Exp Med 20 February 2006; 203 (2): 461–471. doi: https://doi.org/10.1084/jem.20051519
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement